IFNE
Basic information
Region (hg38): 9:21480839-21482313
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IFNE gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 2 | 0 |
Variants in IFNE
This is a list of pathogenic ClinVar variants found in the IFNE region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-21481174-C-T | not specified | Uncertain significance (May 03, 2023) | ||
9-21481246-C-T | not specified | Uncertain significance (Aug 04, 2024) | ||
9-21481249-C-T | not specified | Likely benign (Oct 05, 2022) | ||
9-21481250-G-C | not specified | Uncertain significance (Aug 02, 2021) | ||
9-21481260-T-A | IFNE-related disorder | Likely benign (Apr 14, 2023) | ||
9-21481291-A-G | not specified | Uncertain significance (Feb 15, 2023) | ||
9-21481304-G-T | not specified | Uncertain significance (Aug 21, 2023) | ||
9-21481328-G-C | not specified | Uncertain significance (Dec 04, 2024) | ||
9-21481332-T-A | not specified | Uncertain significance (Jun 28, 2024) | ||
9-21481367-G-C | not specified | Uncertain significance (Dec 14, 2021) | ||
9-21481368-G-T | not specified | Uncertain significance (Jul 05, 2023) | ||
9-21481378-G-A | not specified | Likely benign (Dec 02, 2022) | ||
9-21481385-T-C | not specified | Uncertain significance (Jan 23, 2023) | ||
9-21481417-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
9-21481442-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
9-21481466-T-G | not specified | Uncertain significance (Dec 14, 2022) | ||
9-21481499-A-C | not specified | Uncertain significance (Oct 12, 2024) | ||
9-21481508-G-C | not specified | Uncertain significance (May 31, 2023) | ||
9-21481573-A-C | not specified | Uncertain significance (Mar 31, 2024) | ||
9-21481628-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
9-21481645-G-A | not specified | Uncertain significance (Jan 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IFNE | protein_coding | protein_coding | ENST00000448696 | 1 | 1472 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0147 | 0.700 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.715 | 123 | 103 | 1.20 | 0.00000472 | 1383 |
Missense in Polyphen | 30 | 22.446 | 1.3365 | 351 | ||
Synonymous | -1.43 | 52 | 40.4 | 1.29 | 0.00000200 | 387 |
Loss of Function | 0.634 | 3 | 4.44 | 0.675 | 1.89e-7 | 55 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Type I interferon required for maintaining basal levels of IFN-regulated genes, including 2'-5'-oligoadenylate synthetase, IRF7 and ISG15, in the female reproductive tract. Directly mediates protection against viral and bacterial genital infections (By similarity). {ECO:0000250}.;
- Pathway
- Jak-STAT signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);RIG-I-like receptor signaling pathway - Homo sapiens (human);RIG-I-like Receptor Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.810
- rvis_EVS
- 0.64
- rvis_percentile_EVS
- 83.78
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0651
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ifne
- Phenotype
- hematopoietic system phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- adaptive immune response;T cell activation involved in immune response;natural killer cell activation involved in immune response;humoral immune response;regulation of signaling receptor activity;cytokine-mediated signaling pathway;B cell differentiation;positive regulation of peptidyl-serine phosphorylation of STAT protein;B cell proliferation;defense response to bacterium;response to exogenous dsRNA;defense response to virus
- Cellular component
- extracellular space
- Molecular function
- cytokine activity;type I interferon receptor binding